API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/06/24/2902980/0/en/Biofrontera-Announces-the-Launch-of-a-New-FDA-Approved-Red-Light-Source-the-RhodoLED-XL-Lamp.html
https://www.globenewswire.com/news-release/2022/09/06/2510637/0/en/Biofrontera-Inc-Announces-Notice-of-Allowance-for-Nanoemulsion-Composition-of-Matter-U-S-Patent.html
https://www.expresspharma.in/latest-updates/sun-pharma-presents-clinical-insights-of-odomzo-and-levulan-kerastick-blu-u-data-for-skin-cancer-treatment/
https://www.prnewswire.com/news-releases/sun-pharma-plans-to-present-clinical-insights-from-25-data-abstracts-across-its-dermatology-portfolio-at-the-2020-aad-virtual-meeting-experience-301074129.html
https://www.businesswire.com/news/home/20200303005205/en/Alnylam-Announces-Approval-GIVLAARI%C2%AE-givosiran-European-Union/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
http://www.pharmatimes.com/news/groundbreaking_new_brain_cancer_treatment_available_1287732
https://endpts.com/alnylam-shores-up-enthusiasm-for-givosiran-with-early-dataset-ahead-of-crucial-phiii-readout/
https://www.xconomy.com/boston/2018/10/15/alnylam-wont-seek-quick-fda-nod-for-second-rnai-drug/
https://health.economictimes.indiatimes.com/news/pharma/sun-pharmas-subsidiary-files-patent-infringement-suit-against-german-drug-maker-biofrontera/64954247
http://www.pharmatimes.com/news/nice_backs_use_of_dye_for_brain_tumour_removal_1243902
https://www.fiercebiotech.com/biotech/biofrontera-files-for-ipo-to-run-skin-cancer-clinical-trials
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/how-top-indian-drug-makers-like-sun-pharma-glenmark-are-building-a-brands-business-in-the-us/articleshow/56382828.cms
https://www.pharmacompass.com/pdf/news/biofrontera-pharmas-ameluz-aminolevulinic-acid-hydrochloride-approved-in-us-for-actinic-keratosis-1463053180.pdf
http://www.biospectrumasia.com/biospectrum/news/222435/nz-drug-glows-brain-tumour
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30